SAN JOSE, Calif., March 20, 2024 (GLOBE NEWSWIRE) — Read more »
Nyxoah Annonce que l'Étude Pivot DREAM U.S. Atteint les Critères d'Évaluation Primaires
Nyxoah Annonce que l'Étude Pivot DREAM U.S. Atteint les Critères d'Évaluation Primaires
Le taux de réponse à l'indice [...] Read more »
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
Nyxoah Announces DREAM U.S. Pivotal Study Meets Primary Endpoints
Reports an Apnea–Hypopnea Index (AHI) responder rate of 63.5% on an intent to treat (ITT) basis [...] Read more »
Zoom Named to Fast Company’s Annual List of the World’s Most Innovative Companies of 2024
SAN JOSE, Calif., March 19, 2024 (GLOBE NEWSWIRE) — Zoom Video Communications, Inc. (NASDAQ: ZM), has been named to Fast Company’s prestigious list of the World’s Most Innovative Companies of [...] Read more »
Cellebrite Revolutionizes Data Collection with Ground-breaking SaaS Solution, Integral Part of Company’s Case-to-Closure Platform
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 14, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in Digital Investigative solutions, today unveils Cellebrite Endpoint Inspector SaaS. This [...] Read more »
Fortrea signe un accord définitif pour céder les activités Endpoint Clinical et Patient Access à Arsenal Capital Partners
Le projet de cession des activités Endpoint Clinical et Fortrea Patient Access permet à Fortrea de se recentrer sur son cœur de métier stratégique d’organisme de [...] Read more »
Fortrea unterzeichnet endgültige Vereinbarung zur Veräußerung der Geschäftsbereiche Endpoint Clinical und Patient Access an Arsenal Capital Partners
Vorgeschlagene Veräußerung der Geschäftsbereiche Endpoint Clinical und Fortrea Patient Access optimiert Fortreas strategische Ausrichtung als reines Auftragsforschungsinstitut
Read more »
Fortrea Assina Contrato Definitivo de Transferência das Unidades Endpoint Clinical e Patient Access para a Arsenal Capital Partners
A proposta da transferência das unidades Endpoint Clinical e Fortrea Patient Access agiliza ainda mais o foco estratégico da Fortrea como uma organização de pesquisa sob contrato
Read more »
Fortrea Signs Definitive Agreement to Divest Endpoint Clinical and Patient Access Businesses to Arsenal Capital Partners
Proposed divestiture of Endpoint Clinical and Fortrea Patient Access businesses further streamlines Fortrea’s strategic focus as a pure–play contract research organization
Read more »
Recursion Announces Plans to Open New Office in London
LONDON, March 11, 2024 (GLOBE NEWSWIRE) — Read more »
Entera Bio Announces Full Year 2023 Financial Results and Provides Business Updates
JERUSALEM, March 08, 2024 (GLOBE NEWSWIRE) — Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the “Company”) a leader in the development of orally delivered peptides, today reported financial [...] Read more »
Haim Shani Concludes Tenure at Cellebrite as Company Enters Next Growth Phase
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 06, 2024 (GLOBE NEWSWIRE) — Cellebrite DI Ltd. (Nasdaq: CLBT), a leader in premier Digital Investigative solutions for the public and private sectors, today announced [...] Read more »
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
Nyxoah Reports Fourth Quarter and Financial Year 2023 Financial and Operating Results
Expect to report DREAM U.S. pivotal study efficacy and safety data by early April
Achieved record [...] Read more »
Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2023
Nyxoah Publie ses Résultats Financiers et Opérationnels pour le Quatrième Trimestre et l'Exercice 2023
Les données d'efficacité et de sécurité [...] Read more »
Bitdeer Announces New 4nm Bitcoin Mining Chip SEAL01
SINGAPORE, March 04, 2024 (GLOBE NEWSWIRE) — Bitdeer Technologies Group (NASDAQ: BTDR) (“Bitdeer” or the “Company”), a world–leading technology company [...] Read more »